Company Overview
DocGo Inc. operates as a mobile healthcare services provider serving markets in both the United States and the United Kingdom, delivering essential transportation solutions through its Mobile Health Services and Transportation Services segments. The company functions within the broader Healthcare sector, specifically classified under the Medical Care Facilities industry, where it facilitates the movement of patients and medical equipment for emergency and non-emergency medical needs. This enterprise maintains a market capitalization of $56.80M and generated total revenue of $322.20M over the trailing twelve months, employing a workforce of 2,537 individuals. The combination of a sub-$60M market cap and revenue exceeding $300M suggests the company occupies a niche position within the specialized medical logistics market, characterized by significant operational scale relative to its valuation.
Financial Health
The company reported total revenue of $322.20M for the trailing twelve months, yet this revenue figure masks a substantial loss in profitability with a net income of -$182,399,632 and an EBITDA of -$73,495,296. The considerable gap between the positive revenue stream and the negative net income highlights a highly expansive cost structure where operating expenses, likely driven by labor-intensive transportation and medical service delivery, exceed gross margins. Despite the reported losses, DocGo generated free cash flow of $56.60M, which provides a critical layer of financial flexibility to fund operations or capital investments without immediate reliance on external equity financing. The company holds $51.02M in cash against $29.18M in debt, resulting in a debt-to-equity ratio of 23.18 that indicates a leveraged balance sheet despite the absolute dollar amount of debt being lower than cash reserves. Liquidity analysis shows a current ratio of 2.26, indicating that the company possesses more than twice the current assets necessary to cover its short-term liabilities, which points to a robust short-term liquidity position. However, the return on equity stands at -89.0% and the return on assets is -16.6%, revealing that management is currently unable to generate positive returns on the capital provided by shareholders or the asset base utilized to generate revenue.
Valuation Assessment
Valuation metrics for DocGo Inc. show a trailing twelve-month P/E ratio of N/A due to the lack of recent net income, while the forward P/E is listed at 3.29, implying that the market is pricing in a significant expected recovery in earnings or a re-rating of the stock based on future projections rather than current profitability. The price-to-book ratio is 0.39, indicating that the market values the company at less than 40% of its book value, which suggests the stock is trading at a deep discount relative to its accounting equity. Alternative valuation measures include a price-to-sales ratio of 0.18 and an EV/EBITDA of -0.23, metrics that reflect the company's high revenue generation relative to its current market price but also underscore the negative earnings multiple inherent in its current loss-making status. Regarding trading range, the stock has a 52-week high of $2.86 and a 52-week low of $0.56, and without the current share price provided in the facts, the specific percentage distance from these levels cannot be calculated, but the wide range demonstrates significant price volatility over the last year. The stock exhibits a beta of 0.96, meaning its price volatility is expected to move in tandem with the broader market, showing slightly less sensitivity to market swings than the average stock.
Growth & Income
DocGo Inc. experienced a year-over-year revenue growth of -38.0%, while earnings growth is N/A due to the company's negative net income position. The contraction in revenue indicates a shrinking top line, and since earnings are already negative, comparing the rate of earnings growth to revenue growth is not applicable in the traditional sense of expanding profitability. As the company does not pay dividends, with a dividend yield of N/A and a payout ratio of 0.0%, it does not distribute cash to shareholders but instead retains all earnings, which are currently negative, to fund ongoing operations. The overall growth and income profile for DocGo Inc. is characterized by negative revenue growth and a complete absence of dividend income, reflecting a company in a transitional or distressed phase that prioritizes operational survival over shareholder distribution or top-line expansion.